Development and evaluation of improved substance use disorder treatments such as inhibition training for patients with alcohol use disorders or integrated treatment programs for comorbid psychiatric disorders
Epidemiology, diagnosis, and treatment of attention deficit/hyperactivity disorders (ADHD) in representative samples or in patients with substance use disorders
Understanding of mechanisms of craving, neurophysiological cue-reactivity, and relapse in patients with alcohol use isorders
Predictors of successful treatment courses and in patients with substance use disorders or patients with psychiatric comorbidity.
- Clinical questionnaires and interviews for substance use, psychiatric symptoms, and social functioning.
- Neurophysiological methods such as fMRI and EEG and endocrinological methods such as assessment of cortisol.
- Testing the reliability, validity and applicability of clinical assessments.
- Experimental and observational, cross-sectional and longitudinal, single- and multi-site, and international and international studies